Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16855624rdf:typepubmed:Citationlld:pubmed
pubmed-article:16855624lifeskim:mentionsumls-concept:C0015576lld:lifeskim
pubmed-article:16855624lifeskim:mentionsumls-concept:C0003364lld:lifeskim
pubmed-article:16855624lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:16855624lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:16855624lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:16855624lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:16855624lifeskim:mentionsumls-concept:C0949236lld:lifeskim
pubmed-article:16855624lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:16855624pubmed:issue10lld:pubmed
pubmed-article:16855624pubmed:dateCreated2006-9-21lld:pubmed
pubmed-article:16855624pubmed:abstractTextPulse pressure (PP) is emerging as a major pressure predictor of cardiac disease. The study comprised 10 185 untreated patients with essential hypertension. A total of 5395 men and 4790 women 56+/-13 years old, with uncomplicated essential hypertension, after a 15-day washout period and after 6 months of antihypertensive monotherapy were included. All patients included in the final cohort were responders and had normalized their blood pressure. PP was decreased least with diuretics (-5 mm Hg) and most with angiotensin II receptor blockers (ARBs) and calcium antagonists (-15 mm Hg), followed by angiotensin-converting enzyme inhibitors (ACEI) (-12 mm Hg) alpha- and beta-blockers (-10 and -9 mm Hg), differentiating among antihypertensive classes (P<0.001). The magnitude of PP fall was related to the degree of left ventricular (LV) mass reduction (P<0.001), seen best with ARBs (r=0.42) and least with ACEIs (r=0.18). Of the antihypertensive medications used in everyday practice, PP decrease may be achieved best with ARBs and calcium antagonists, whereas diuretics confer poor response. PP was decreased least with diuretics (-5 mm Hg) and most with ARBs and calcium channel blockers (-15 mm Hg), followed by ACEI (-12 mm Hg) alpha- and beta-blockers (-10 and -9 mm Hg), differentiating among antihypertensive classes (P<0.001). Of the antihypertensive medications used in everyday practice, PP decrease may be achieved best with ARBs and calcium antagonists.lld:pubmed
pubmed-article:16855624pubmed:languageenglld:pubmed
pubmed-article:16855624pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16855624pubmed:citationSubsetIMlld:pubmed
pubmed-article:16855624pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16855624pubmed:statusMEDLINElld:pubmed
pubmed-article:16855624pubmed:monthOctlld:pubmed
pubmed-article:16855624pubmed:issn0950-9240lld:pubmed
pubmed-article:16855624pubmed:authorpubmed-author:CokkinosD VDVlld:pubmed
pubmed-article:16855624pubmed:authorpubmed-author:VyssoulisG...lld:pubmed
pubmed-article:16855624pubmed:authorpubmed-author:KarpanouE AEAlld:pubmed
pubmed-article:16855624pubmed:authorpubmed-author:StefanadisC...lld:pubmed
pubmed-article:16855624pubmed:issnTypePrintlld:pubmed
pubmed-article:16855624pubmed:volume20lld:pubmed
pubmed-article:16855624pubmed:ownerNLMlld:pubmed
pubmed-article:16855624pubmed:authorsCompleteYlld:pubmed
pubmed-article:16855624pubmed:pagination765-71lld:pubmed
pubmed-article:16855624pubmed:meshHeadingpubmed-meshheading:16855624...lld:pubmed
pubmed-article:16855624pubmed:meshHeadingpubmed-meshheading:16855624...lld:pubmed
pubmed-article:16855624pubmed:meshHeadingpubmed-meshheading:16855624...lld:pubmed
pubmed-article:16855624pubmed:meshHeadingpubmed-meshheading:16855624...lld:pubmed
pubmed-article:16855624pubmed:meshHeadingpubmed-meshheading:16855624...lld:pubmed
pubmed-article:16855624pubmed:meshHeadingpubmed-meshheading:16855624...lld:pubmed
pubmed-article:16855624pubmed:meshHeadingpubmed-meshheading:16855624...lld:pubmed
pubmed-article:16855624pubmed:meshHeadingpubmed-meshheading:16855624...lld:pubmed
pubmed-article:16855624pubmed:meshHeadingpubmed-meshheading:16855624...lld:pubmed
pubmed-article:16855624pubmed:meshHeadingpubmed-meshheading:16855624...lld:pubmed
pubmed-article:16855624pubmed:meshHeadingpubmed-meshheading:16855624...lld:pubmed
pubmed-article:16855624pubmed:meshHeadingpubmed-meshheading:16855624...lld:pubmed
pubmed-article:16855624pubmed:year2006lld:pubmed
pubmed-article:16855624pubmed:articleTitleDifferential pulse pressure response to various antihypertensive drug families.lld:pubmed
pubmed-article:16855624pubmed:affiliation1st Department of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece. eva_karpanou@mailbox.grlld:pubmed
pubmed-article:16855624pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16855624pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16855624lld:pubmed